Key result
Molecular biomarkers are advancing in cardiology to improve the management of cardiovascular diseases, which remain the leading cause of death globally despite new therapies.
Key points are not available for this paper at this time.
Design
Review
A review discussing advances in molecular biomarkers for cardiovascular diseases.
Cardiovascular diseases (CVD) represent the leading cause of death in the world despite innovations in therapies and advances in the general management of patients [...].
No takes yet. Share an insight, caveat, or question.
Scicchitano et al. (2022) studied this question. Molecular biomarkers are advancing in cardiology to improve the management of cardiovascular diseases, which remain the leading cause of death globally despite new therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: